High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

S Cascinu, M Scartozzi, R Labianca, V Catalano, R R Silva, S Barni, A Zaniboni, A D'Angelo, S Salvagni, G Martignoni, G D Beretta, F Graziano, R Berardi, V Franciosi

Journal: British journal of cancer 2004;90(8):1521-5

PMID: 15083179

Free Full Text on PubMed Central View on PubMed

Abstract

The aim of the present study was to evaluate the role of a weekly preoperative chemotherapy in locally advanced, unresectable gastric cancer. In all, 82 patients with an Eastern Oncology Cooperative Group PS

Address: Clinica di Oncologia, Università Politecnica delle Marche-Azienda Ospedaliera Umberto I, via Conca, Ancona 60020, Italy. [email protected]

DOI: 10.1038/sj.bjc.6601752

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/stomachcancer.html

Subscription / membership required

Full Text Sources:

https://doi.org/10.1038/sj.bjc.6601752

MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Disease-Free Survival, Drug Administration Schedule, Epirubicin, Female, Filgrastim, Fluorouracil, Glutathione, Granulocyte Colony-Stimulating Factor, Humans, Leucovorin, Leukopenia, Levoleucovorin, Male, Middle Aged, Neoadjuvant Therapy, Recombinant Proteins, Stomach Neoplasms, Thrombocytopenia, Treatment Outcome